These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 24900074)
21. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma? Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT. Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320 [TBL] [Abstract][Full Text] [Related]
23. Bone involvement in patients with lymphoma: the role of FDG-PET/CT. Schaefer NG; Strobel K; Taverna C; Hany TF Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):60-7. PubMed ID: 17021808 [TBL] [Abstract][Full Text] [Related]
24. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma. Albano D; Patti C; Lagalla R; Midiri M; Galia M J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267 [TBL] [Abstract][Full Text] [Related]
25. Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre Doma A; Zevnik K; Studen A; Prevodnik VK; Gasljevic G; Novakovic BJ Radiol Oncol; 2024 Mar; 58(1):15-22. PubMed ID: 38378029 [TBL] [Abstract][Full Text] [Related]
26. The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers. Yağci-Küpeli B; Koçyiğit-Deveci E; Adamhasan F; Küpeli S J Pediatr Hematol Oncol; 2019 Aug; 41(6):438-441. PubMed ID: 31033787 [TBL] [Abstract][Full Text] [Related]
27. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
28. Assessing bone marrow involvement in diffuse large B-cell lymphoma with 18F-FDG PET/CT: A preliminary experience at Hospital Pulau Pinang. Siti Maisarah MN; Mahayuddin AM; Fadzilah H Med J Malaysia; 2021 Sep; 76(5):665-671. PubMed ID: 34508372 [TBL] [Abstract][Full Text] [Related]
29. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874 [TBL] [Abstract][Full Text] [Related]
30. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723 [TBL] [Abstract][Full Text] [Related]
31. 18f-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients. Aguado-Vázquez TM; Olivas-Martínez A; Cancino-Ramos U; Zúñiga-Tamayo DA; Lome-Maldonado MDCA; Rivas-Vera S; García-Pérez FO; Candelaria-Hernández MG Rev Invest Clin; 2020 May; 73(5):. PubMed ID: 33048916 [TBL] [Abstract][Full Text] [Related]
32. Yang C; Wu W; Zhou H; Zhao S; Tian R; Xiang M; Zou L Front Oncol; 2022; 12():894804. PubMed ID: 35965550 [TBL] [Abstract][Full Text] [Related]
33. Exploring the role of FDG-PET in the assessment of bone marrow involvement in lymphoma patients as interpreted by qualitative and semiquantitative disease metabolic activity parameter. Kand PG; Tiwari BP; Basu S; Asopa RV; Nayak UN Indian J Cancer; 2010; 47(4):380-4. PubMed ID: 21131749 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of Öner AO; Sürer Budak E; Aydın F; Salim O; Yücel OK; Akkaya B; Toptaş T; Boz A; Yıldız A; Güngör F; Undar L Mol Imaging Radionucl Ther; 2017 Jun; 26(2):69-75. PubMed ID: 28613199 [TBL] [Abstract][Full Text] [Related]
35. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
36. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy. Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215 [TBL] [Abstract][Full Text] [Related]
37. The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors. Arslantaş E; Ayçiçek A; Esen Akkas B; Tahtakesen Güçer TN; Okur Acar S; Özkan Karagenc A; Akpınar Tekgündüz S; Bayram C Nuklearmedizin; 2024 Jun; 63(3):207-212. PubMed ID: 38190995 [TBL] [Abstract][Full Text] [Related]
38. The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study. Alzahrani M; El-Galaly TC; Hutchings M; Hansen JW; Loft A; Johnsen HE; Iyer V; Wilson D; Sehn LH; Savage KJ; Connors JM; Gascoyne RD; Johansen P; Clasen-Linde E; Brown P; Villa D Ann Oncol; 2016 Jun; 27(6):1095-1099. PubMed ID: 27002106 [TBL] [Abstract][Full Text] [Related]
39. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348 [TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of Bone Marrow F-18 FDG Uptake in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma. Wang J; Kim D; Kang WJ; Cho H Nucl Med Mol Imaging; 2020 Feb; 54(1):28-34. PubMed ID: 32206128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]